The preclinical drug discovery landscape across the United States is undergoing a profound structural re-alignment, characterized by a massive acceleration in automated screening platforms and safety profiling protocols. The long-term commercial expansion of the US ADME Toxicology Testing Market continues to hit record milestones as domestic pharmaceutical and biotechnology networks work...
Bangla